Evidence map›Paper›PMID 39253215›Full record

ArticleHeliyon2024

Development of deep learning model for diagnosing muscle-invasive bladder cancer on MRI with vision transformer.

Yasuhisa Kurata, Mizuho Nishio, Yusaku Moribata, Satoshi Otani, Yuki Himoto, Satoru Takahashi, Jiro Kusakabe, Ryota Okura, Marina Shimizu, Keisuke Hidaka and 8 more

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Observational
  3. Current Status and Future Perspective for Bladder Cancer MR Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in Japan: Challenges and Solutions.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yasuhisa KurataDepartment of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54, Shogoin Kawahara-cho, Sakyo-Ku, Kyoto, 606-8507, Japan.
Mizuho NishioDepartment of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54, Shogoin Kawahara-cho, Sakyo-Ku, Kyoto, 606-8507, Japan.
Yusaku MoribataDepartment of Radiology, Shiga General Hospital, 4-30, Moriyama 5-chome, Moriyama-shi, Shiga, 524-8524, Japan.
Satoshi OtaniDepartment of Radiology, Kyoto City Hospital, 2-1 Mibu Higashi Takada-cho Nakagyo-ku, Kyoto, 604-8845, Japan.
Yuki HimotoDepartment of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54, Shogoin Kawahara-cho, Sakyo-Ku, Kyoto, 606-8507, Japan.
Satoru TakahashiDepartment of Radiology, Takatsuki General Hospital, 1-3-13, Kosobe-Cho, Takatsuki-Shi, Osaka, 569-1192, Japan.
Jiro KusakabeDepartment of General Surgery, Cleveland Clinic, Cleveland, OH, USA.
Ryota OkuraDepartment of Radiology, Kyoto City Hospital, 2-1 Mibu Higashi Takada-cho Nakagyo-ku, Kyoto, 604-8845, Japan.
Marina ShimizuDepartment of Radiology, Kyoto City Hospital, 2-1 Mibu Higashi Takada-cho Nakagyo-ku, Kyoto, 604-8845, Japan.
Keisuke HidakaDepartment of Radiology, Osaka Red Cross Hospital, 5-30 Fudegasakicho, Tennoji-ku, Osaka, 543-0027, Japan.
Naoko NishioDepartment of Radiology, Osaka Red Cross Hospital, 5-30 Fudegasakicho, Tennoji-ku, Osaka, 543-0027, Japan.
Akihiko FurutaDepartment of Radiology, Osaka Red Cross Hospital, 5-30 Fudegasakicho, Tennoji-ku, Osaka, 543-0027, Japan.
Aki KidoDepartment of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54, Shogoin Kawahara-cho, Sakyo-Ku, Kyoto, 606-8507, Japan.
Kimihiko MasuiDepartment of Urology, Kyoto University Hospital, 54 Shogoin Kawahara-cho, Sakyo-Ku, Kyoto, 606-8507, Japan.
Hiroyuki OnishiDepartment of Urology, Osaka Red Cross Hospital, 5-30 Fudegasakicho, Tennoji-ku, Osaka, 543-0027, Japan.
Takehiko SegawaDepartment of Urology, Kyoto City Hospital, 2-1 Mibu Higashi Takada-cho Nakagyo-ku, Kyoto, 604-8845, Japan.
Takashi KobayashiDepartment of Urology, Kyoto University Hospital, 54 Shogoin Kawahara-cho, Sakyo-Ku, Kyoto, 606-8507, Japan.
Yuji NakamotoDepartment of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54, Shogoin Kawahara-cho, Sakyo-Ku, Kyoto, 606-8507, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rationale and objectives: To develop and validate a deep learning (DL) model to automatically diagnose muscle-invasive bladder cancer (MIBC) on MRI with Vision Transformer (ViT). Materials and methods: This multicenter retrospective study included patients with BC who reported to two institutions between January 2016 and June 2020 (training dataset) and a third institution between May 2017 and May 2022 (test dataset). The diagnostic model for MIBC and the segmentation model for BC on MRI were developed using the training dataset with 5-fold cross-validation. ViT- and convolutional neural network (CNN)-based diagnostic models were developed and compared for diagnostic performance using the area under the curve (AUC). The performance of the diagnostic model with manual and auto-generated regions of interest (ROI Results: The training and test datasets included 170 and 53 patients, respectively. Mean AUC of the top 10 ViT-based models with 5-fold cross-validation outperformed those of the CNN-based models (0.831 ± 0.003 vs. 0.713 ± 0.007-0.812 ± 0.006, p < .001). The diagnostic model with ROI Conclusion: The DL model effectively diagnosed MIBC. The ViT-based model outperformed CNN-based models, highlighting its utility in medical image analysis.

Indexed as

Bladder cancerConvolutional neural networkDeep learningMRIVision transformer

Identifiers

PMID39253215
PMCPMC11381713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.